|
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101) |
|
|
|
Titel: |
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101) |
Auteur: |
Nishioka, Naoya Imai, Hisao Endo, Masahiro Notsu, Akifumi Doshita, Kosei Igawa, Satoshi Yokouchi, Hiroshi Ninomiya, Takashi Tokito, Takaaki Soda, Sayo Fujiwara, Takasato Asao, Tetsuhiko Nakamichi, Shinji Kawamura, Takahisa Inomata, Minehiko Nakashima, Kazuhisa Ito, Kentaro Goto, Yasuhiro Umeda, Yukihiro Hirai, Soichi Ushio, Ryota Yokoo, Keiki Takeda, Takayuki Fukui, Tomoya Ishihara, Masashi Osaki, Takashi Kubo, Sousuke Fujiwara, Takumi Yamamoto, Chie Tsuda, Takeshi Tamura, Nobumasa Hosokawa, Shinobu Chihara, Yusuke Ikeda, Satoshi Furuya, Naoki Nakahara, Yoshiro Miura, Satoru Okamoto, Hiroaki |
Verschenen in: |
Targeted oncology |
Paginering: |
Jaargang 19 () nr. 3 pagina's 423-433 |
Jaar: |
2024-04-13 |
Inhoud: |
|
Uitgever: |
Springer International Publishing, Cham |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|